References
- Fitzgerald D J, Rocki W, Murray R, Mayo G, Fitzgerald G A, Thromboxane A. synthesis in pregnancy-induced hypertension. Lancet 1990; 1: 751–4
- Van Geet C, Spitz B, Vermylen J, Van Assche A. Urinary thromboxane metabolites in pre-eclampsia. Lancet 1990; 1: 1168–9
- Socol M L, Weiner C P, Louis G, Rehnberg K, Rossi EC. Platelet activation in preeclampsia. Am J Obstet Gynecol 1985; 151: 494–7
- Janes S L, Goodall AH. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci 1994; 86: 731–9
- Csaicsich P, Deutinger J, Tatra G. Platelet specific proteins (β-thromboglobulin and platelet factor 4 in normal pregnancy and in pregnancy complicated by preeclampsia. Arch Gynecol Obstet 1989; 244: 91–5
- Ballageer V C, Spitz B, De Baene L A, Van Assche A F, Hidajat M, Criel AM. Platelet activation and vascular damage in gestational hypertension. Am J Obstet Gynecol 1992; 166: 629–33
- Lees C, Langford E, Brown A S, De Belder A, Pickles A, Martin J F. The effects of s-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia. Obstet Gynaecol 1996; 88: 14–9
- O'Brien W F, Saba H I, Knuppel R A, Scerbo J C, Cohen GR. Alterations in platelet concentration and aggregation in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1986; 155: 486–90
- Louden K A, Broughton Pipkin F, Heptinstall S, Fox S C, Mitchell J R, Symmonds EM. Platelet reactivity and serum thromboxane B production in whole blood in gestational hypertension and pre-eclampsia. Br J Obstet Gynaecol 1991; 98: 1239–44
- Greer I A, Calder A A, Walker J J, Lunan C B, Tulloch I. Increased platelet reactivity in pregnancy-induced hypertension and uncomplicated diabetic pregnancy: an indication for anti-platelet therapy. Br J Obstet Gynaecol 1988; 95: 1204–8
- Whigham K AE, Howie P W, Drummond A H, Prentice C RM. Abnormal platelet function in pre-eclampsia. Br J Obstet Gynaecol 1978; 85: 28–32
- Norris L A, Sheppard B L, Burke G, Bonnar J. Platelet activation in normotensive and hypertensive pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynaecol 1994; 101: 209–14
- Hornstra G, Ten Hor F. The filtragometer: a new device for measuring platelet aggregation in venous blood in man. Thromb Diath Haemorrhag 1975; 34: 531–44
- Marsal K, Persson P H, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996; 85: 843–8
- Fleischman A I, Bierenbaum M L, Stier D JA, Sullivan A. In vivo platelet function in myocardial infarction acute cerebrovascular accidents and following surgery. Thromb Res 1975; 6: 205–7
- Cardinal D C, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behaviour in blood. J Pharmacol Methods 1980; 3: 135–58
- Ahmed Y, Sullivan M H, Elder MG. Selection of platelet desensitisation in pregnancy induced hypertension is dependent on the agonist used. Thromb Haemostas 1991; 65: 474–7
- Karlberg K E, Chen J, Egberg N, Nowak J, Sylvén C. Comparison of three independent methods as estimates of platelet inhibition after a single dose of acetylsalicylic acid. Scand J Lab Invest 1993; 53: 835–41
- Weiner CP. The mechanism of reduced antithrombin III activity in women with preeclampsia. Obstet Gynecol 1988; 72: 847–9
- De Boer K, Ten Cate J W, Sturk A, Born J JJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989; 160: 95–100
- Perry K G, Martin JN. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia. Clin Obstet Gynecol 1992; 35: 338–50